GENMAB A/S GMAB

BulutBozkurt Pro

I have sold all of my genmab shares i started to buy at the start of corona, 5 year tmeframe i think we see a head an shoulder formation an hoping to buy again 15-1600 kr :)

BulutBozkurt Pro

Hello again, i bought this stock last year at like 1500 kr, but unf. i see a Head an should forming in think it will fall a little back, of course i hope im wrong an go up from here :) An not selling holding at least 5-20 years :)

StockBullDenmark Premium

Adjusted

StockBullDenmark Premium

Looks like we have a cup with handle. Potential target 3600-3800

StragaFX

If you own it keep it otherwise buy

PersonalFinanceDude

steamloss in the Genmab stock will likely fuel a new rush. 1) the 2 previous times times RSI has been below 30, it has resulted in strong returns. Will it happen a 3rd time? 2) The current strongly rising RSI will like make sure that the price will move and stay above the short term downward trend. 3) Opportunity for the price to move towards 2557 DKK. Yet be...

StragaFX

Support has done its job: buy signal has been confirmed

Neslos

sell

gibbsys

Some basic chart analysis on Genmab. This is more to bring your attention to the stocks long term growth prospects. With a TTM P/E ratio of 29 and a FWD of 3, combined with solid revenue growth TTM and FWD leads me to suggest that Genmab will thrive in the coming months and climb to all time highs.

ELHASSANE-TRA

GENMAB A/S Our contribution has known a strong acceleration and impressive upward defense positive and still He is on a strong track and the prospect of purchase is still A fresh list of buyers' abundance and strong size

savepiginvest Pro

November 4, 2020; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2020 Highlights Novartis granted U.S. FDA approval for Kesimpta® (ofatumumab) in relapsing multiple sclerosis Janssen and European Myeloma Network achieved positive topline results from Phase 3 APOLLO study of daratumumab in relapsed or refractory multiple...

M_Andreasen

After the royalty issue with Janssen announced today we have seen a sudden decrease. I would say 2000 DKK is a buying zone/support level and it must be held if the stock price should rise to new ATH again.

ALAOUAL

GMAB will continue to climb in the coming days Because we are above the blue line and we have a green candle that corresponds to raising the volume

Neslos

sell

jonathan_winther

G-mab

Charlestrad3r

Back in late 2014 Genmab broke out and haven't looked back since, though it have seen many downturns on the way, as we can see it has been through 4 big downturns of 25%+ drops. Another one could be in motion, a weekly bearish engulfing candle has formed and we have seen it drop 15% and is now back testing the former resistance and is about to test the bottom...

Charlestrad3r

Weekly cup & Handle Since making new highs, there have been a slight pull back but the trendline stays intact and it remains in an uptrend. The trend is strong high above 50 week MA and preparing for a possible breakout to new highs. Don't fight the trend. Don't be scared of new highs. Catalyst 2020: Cervical Cancer Phase 2 data due 1H DARZALEX ENHANCE PDUFA...

SimpleinvestMarttin Updated 

Trend channel started in Nov 2018 and have been holding the channel for over 1 year Will it keep going? Still a up trend holding the channel 50 ma holding more then nicely support/resistens at 1453 ish just hit the low of the channel my signals say buy, so here is my idea. Open trade at :1475 Set my TP at :1715 Set my SL at :1445 (if there...